Respiratory Syncytial Virus Infection among Adults after Hematopoietic Stem Cell Transplantation.

Autor: Samad SA; Department of Medicine, AIIMS, New Delhi, India., Jethani J; Department of Microbiology, AIIMS, New Delhi, India., Kumar L; Department of Medical Oncology, AIIMS, New Delhi, India., Choudhary A; Department of Microbiology, AIIMS, New Delhi, India., Brijwal M; Department of Microbiology, AIIMS, New Delhi, India., Dar L; Department of Microbiology, AIIMS, New Delhi, India.
Jazyk: angličtina
Zdroj: Journal of global infectious diseases [J Glob Infect Dis] 2022 Aug 26; Vol. 14 (3), pp. 112-116. Date of Electronic Publication: 2022 Aug 26 (Print Publication: 2022).
DOI: 10.4103/jgid.jgid_11_22
Abstrakt: Introduction: Respiratory syncytial virus (RSV) is a common cause of morbidity among hematopoietic stem cell transplant (HSCT) recipients, with RSV-associated lower respiratory tract infection carrying high mortality rates. There have been no large studies till date, describing the incidence, clinical features, and outcomes of RSV infection among adult HSCT recipients in India.
Methods: A prospective cohort of 100 adults who underwent HSCT was followed up for a maximum period of 18 months starting from the date of transplantation for any episode of respiratory tract infectious disease (RTID). Respiratory samples were collected for laboratory confirmation of the presence and subtyping of RSV by real-time reverse transcriptase-polymerase chain reaction.
Results: The study population comprised of 66% (66/100) males and 34% (34/100) females. Autologous HSCT recipients constituted 78% (78/100) and allogeneic HSCT recipients constituted 22% (22/100) of the study population. The incidence of RSV-RTID among adults after HSCT was 0.82/100 patient months. Most cases occurred during the winter season and the predominant subtype was RSV-A (9/11, 81.8%). Lower RTID was the most common clinical diagnosis made at presentation (9/11, 81.8%). Female gender was predictive of RSV-RTID (log rank P = 0.002). All the RSV-RTID episodes recovered completely without targeted therapy.
Conclusion: RSV is a significant cause of morbidity among adult HSCT recipients in India. Prophylaxis and treatment measures need to be instituted after a proper risk-benefit assessment. Longitudinal studies with larger sample sizes are needed to confirm these results.
Competing Interests: There are no conflicts of interest.
(Copyright: © 2022 Journal of Global Infectious Diseases.)
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje